RCE Charts, page-2163

https://en.m.wikipedia.org/wiki/Moderna

I was suprised to learn Moderna is only a few short years older than Recce. I think it serves as a good example of what can happen in a relatively short amount of time when a new class of biotechnology is developed.

Obviously many hoops to jump through between now and when Recce is in the same stage of commercialisation, but it does make you think of what might be possible.

If Recce were to ever reach the same valuation as Moderna (I know I know it's a moonshot) that would represent around $620 AUD a share. I'm not suggesting we will ever reach that price, but my main point is it doesn't necessarily take decades for a biotechs to reach these stratospheric valuations if the product works.